CME Group plans to launch 24/7 crypto derivatives trading in early 2026

ArTara Therapeutics, Inc. announces that the company's research and development pipeline is progressing smoothly, and key clinical trials are advancing according to the established schedule.

According to the latest documents disclosed by the U.S. Securities and Exchange Commission (SEC), biopharmaceutical company Oric Pharmaceuticals Inc. (ORIC) has announced the launch of an equity offering plan.

Diversified Healthcare Trust releases latest performance outlook, expects total revenue (REV) for fiscal year 2026 to grow by approximately 8.0%

Annual financial data disclosed by specialty chemicals supplier Quaker Houghton shows that the company’s net sales for the year reached $1.89 billion.